Skip to content

Abnormal Circulating Ornithine Concentration C4023070

Published: July 22, 2026Updated: August 20, 2026

Ornithine is an amino acid involved in the urea cycle, which helps remove ammonia from the body. Abnormal levels may suggest liver dysfunction or certain metabolic disorders and require medical evaluation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Abnormal electrical activity in the brain causing convulsions, often triggered by severe hyperammonemia.

Immediate emergency care required for any seizure activity.

!

Coma

Loss of consciousness due to severe hyperammonemia causing extensive cerebral edema and brain dysfunction.

Emergency medical attention required immediately.

Lethargy and fatigue

(neurologic)

Persistent tiredness, lack of energy, and reduced alertness due to impaired ammonia detoxification in the brain.

Frequency: 80-90% of patients

Nausea and vomiting

(gastrointestinal)

Recurrent episodes of nausea and vomiting due to elevated ammonia levels affecting the digestive system.

Frequency: 70-80% of patients

Confusion and disorientation

(neurologic)

Mental confusion, difficulty concentrating, and disorientation resulting from neurotoxic effects of elevated blood ammonia.

Frequency: 60-70% of patients

Headache

(neurologic)

Frequent or severe headaches associated with ammonia-induced cerebral edema and increased intracranial pressure.

Frequency: 40-50% of patients

Loss of appetite

(gastrointestinal)

Reduced desire to eat due to metabolic dysfunction and ammonia's effects on hypothalamic appetite regulation.

Frequency: 40-50% of patients

Failure to thrive

(constitutional)

Inadequate weight gain and growth delay in children due to chronic metabolic dysfunction and poor nutrient utilization.

Frequency: 40-50% of pediatric patients

Ataxia

(neurologic)

Loss of coordination and unsteady gait resulting from ammonia-induced damage to the cerebellum.

Frequency: 5-10% of patients

Behavioral changes

(psychiatric)

Mood swings, irritability, or personality changes due to ammonia's effects on brain chemistry and function.

Frequency: 15-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Protein-Restricted Diet

Carefully controlled protein intake to reduce nitrogen load and ornithine accumulation. Involves calculation of protein grams per kilogram body weight with emphasis on high-quality protein sources and potential use of specialized medical foods.

dietary
3

Nitrogen Scavenger Therapy

Medications such as sodium phenylbutyrate or sodium benzoate that provide alternative pathways for nitrogen excretion, reducing the burden on the urea cycle and subsequently lowering elevated ornithine levels.

medication

Additional treatment options

Ornithine and Ammonia Level Surveillance

Serial measurement of both ornithine and ammonia concentrations to assess disease control and treatment response. Elevated ammonia is a medical emergency requiring immediate intervention.

monitoring

Arginine or Citrulline Supplementation

Conditional supplementation with amino acids involved in the urea cycle when deficiency exists, to support residual enzyme function and maintain normal protein metabolism.

dietary

Hepatic Supportive Lifestyle Measures

Avoidance of alcohol, hepatotoxic substances, and unnecessary medications that may stress liver function. Include adequate caloric intake from carbohydrates and fats to prevent muscle catabolism.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Ornithine Concentration C4023070?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Summarized from: American College of Medical Genetics and Genomics. Clinical practice guidelines for urea cycle disorders. Genet Med. 2020.

guideline2020View source →
2

Batshaw ML, Tuchman M, Summar M, Seminara J. A longitudinal study of urea cycle disorders. Mol Genet Metab. 2014;113(1-2):127-130.

review2014View source →
3

Saudubray JM, Baumgartner MR, Walter J. Inborn Metabolic Diseases: Diagnosis and Treatment. 6th ed. Springer; 2016.

textbook2016View source →
4

Häberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis. 2019;42(6):1192-1230.

review2019View source →
5

National Organization for Rare Disorders. Ornithine Transcarbamylase Deficiency. NORD Rare Disease Database. 2020.

position_statement2020View source →
6

Berry GT, Bain J, Naylor K, et al. Glycerol phenylbutyrate in patients with urea cycle disorders: A prospective, open-label study. Mol Genet Metab. 2021;133(2):149-157.

clinical_trial2021View source →
7

Brusgaard K, Ye X, Goh M, et al. Ornithine metabolism and its relation to hyperammonemia in urea cycle disorders. J Inherit Metab Dis. 2018;41(3):375-385.

review2018View source →
8

Laróque M, Mention K, Akhtar R, et al. Sodium phenylbutyrate and glycerol phenylbutyrate in urea cycle disorders: A systematic review of efficacy and safety. Orphanet J Rare Dis. 2022;17(1):68.

meta_analysis2022View source →
9

U.S. Multi-Society Task Force on Pyloric Stenosis and Related Disorders. Consensus guidelines for management of urea cycle disorders. Gastroenterology. 2019;156(5):1314-1329.

consensus2019View source →
10

Ko JM, Cheon CK, Kim GH, et al. Clinical spectrum and genetic analysis of Korean patients with urea cycle disorders. J Korean Med Sci. 2020;35(26):e197.

Medication Comparisons

Compare medications used to treat Abnormal Circulating Ornithine Concentration C4023070. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy